Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02919670 · FLOW

Participant flow

A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma · Source last updated 2023-03-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    * Two 8 oz. bottles of Enterade will be administered daily * Enterade will be given orally from admission until day +14 or until discharge * Standard Supportive Care will be administered according to institution's practice Enterade Standard Supportive Care
    id
    FG000
    title
    Enterade and Standard Supportive Care
  2. description
    * Two 8 oz. bottles of Placebo will be administered daily * Placebo will be given orally from admission until day +14 or until discharge * Standard Supportive Care will be administered according to institution's practice Placebo Standard Supportive Care
    id
    FG001
    title
    Placebo and Standard Supportive Care
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        43
      2. group Id
        FG001
        num Subjects
        39
      type
      Only 17 participants met compliance
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        49
      2. group Id
        FG001
        num Subjects
        50
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        6
      2. group Id
        FG001
        num Subjects
        11
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        43
      2. group Id
        FG001
        num Subjects
        39
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
Of 114, 6 patients did not receive transplant and 1 patient had a delayed transplant..5 patients withdrew consent , 1 patient did not take any amount due to the finding mold, 1 patient did not take due to subjects inability to swallow liquids and 1 patient had an insurance issue. Thus a total of 15 patients are excluded. (114-15=99).
recruitment Details
Participants were recruited from 10/5/2016 - 10/05/2017
Complete source fields
groups
  1. description
    * Two 8 oz. bottles of Enterade will be administered daily * Enterade will be given orally from admission until day +14 or until discharge * Standard Supportive Care will be administered according to institution's practice Enterade Standard Supportive Care
    id
    FG000
    title
    Enterade and Standard Supportive Care
  2. description
    * Two 8 oz. bottles of Placebo will be administered daily * Placebo will be given orally from admission until day +14 or until discharge * Standard Supportive Care will be administered according to institution's practice Placebo Standard Supportive Care
    id
    FG001
    title
    Placebo and Standard Supportive Care
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        43
      2. group Id
        FG001
        num Subjects
        39
      type
      Only 17 participants met compliance
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        49
      2. group Id
        FG001
        num Subjects
        50
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        6
      2. group Id
        FG001
        num Subjects
        11
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        43
      2. group Id
        FG001
        num Subjects
        39
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
Of 114, 6 patients did not receive transplant and 1 patient had a delayed transplant..5 patients withdrew consent , 1 patient did not take any amount due to the finding mold, 1 patient did not take due to subjects inability to swallow liquids and 1 patient had an insurance issue. Thus a total of 15 patients are excluded. (114-15=99).
recruitment Details
Participants were recruited from 10/5/2016 - 10/05/2017

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice